Contrasting roles for TLR ligands in HIV-1 pathogenesis.
about
Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical TissuesFrequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapyA common path to innate immunity to HIV-1 induced by Toll-like receptor ligands in primary human macrophages.A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages.Upregulation of BST-2/Tetherin by HIV infection in vivo.Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogensHIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infection.Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.Neisseria gonorrhoeae-derived heptose elicits an innate immune response and drives HIV-1 expressionStimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyInduction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?Myeloid dendritic cells in HIV-1 infection.Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells.Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment.HIV Infection and TLR Signalling in the Liver.T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication.HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.HIV-1 control in battlegrounds: important host genetic variations for HIV-1 mother-to-child transmission and progression to clinical pediatric AIDS
P2860
Q28545896-512AEB1E-B68E-491B-B224-05599D4F4751Q28741958-6435E56C-4329-4742-B09B-F81F8B0C24C7Q34014512-7997F1C6-E3C8-410D-81E7-A2B3657213C9Q34426498-AAB0B05A-E699-4CA1-A06A-085710F876A5Q35275193-D6815583-2353-4FBA-B610-B02CF969C8B4Q36352579-BD758CB7-17ED-45D9-B9BF-8FDF220F3A68Q36352592-94657327-6087-42A4-8272-20FA39BCB2F3Q36665377-AD18FD66-2074-4CFB-911E-77B93581DBB6Q36694953-8C2D26AE-66DD-4BD8-8331-5C2FE81C3CA2Q36807121-D4AEA8AD-2B49-4935-89E1-B30E22873101Q36842185-D556DF02-170A-444C-9E5D-1B1919DEF682Q36950468-650A49DB-308F-4EF6-9FEA-0DF1BE091156Q37513027-0D7B736B-7AF3-44A9-BFCC-7C6CB8596D64Q37827571-C60A6D82-3B26-48E1-9205-82CD499B5958Q37899725-1E1E59AE-48CF-4043-88B2-758C14181E79Q38727211-60AC7C7A-CF55-4B8B-B271-AE0ECCF50983Q40305499-1EE3DF21-C510-4623-B8CA-B2CCFF06B148Q40343146-50DDF013-C35A-413C-825C-F4B476BC4A9FQ41788831-8C8E0BDE-AFF8-4DC9-BE1F-16FABAB171DBQ41814282-4D6108AC-2042-42F4-A1AF-99C11A8CC61BQ41849777-1E1729A9-F4B3-4D92-BB2C-1D91A1000AFCQ42207253-9D2D584B-0F5F-47D2-8D37-A416799D73F3Q56762889-10BB65F3-FC8F-410F-8D0E-718A807AA1E2
P2860
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@ast
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@en
type
label
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@ast
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@en
prefLabel
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@ast
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@en
P2093
P2860
P1433
P1476
Contrasting roles for TLR ligands in HIV-1 pathogenesis.
@en
P2093
Andrea Lisco
Angelique Biancotto
Beda Brichacek
Christophe Vanpouille
Jean Charles Grivel
Leonid Margolis
Melanie Merbah
Yana Kiselyeva
P2860
P356
10.1371/JOURNAL.PONE.0012831
P407
P50
P577
2010-09-20T00:00:00Z